Companies / Pliant Therapeutics, Inc.

Pliant Therapeutics, Inc.

Nasdaq: PLRXCIK 1746473SOUTH SAN FRANCISCO, CApliantrx.com ↗

Financials · FY2025

Revenue$0
Net income$-149.34M
Total debt$0
Cash$24.88M
Diluted EPS$-2.43
Shares outstanding61.9M

Ownership

61.9M shares outstanding · as of Aug 7, 2026
1.4%Insiders
Ownership
Insiders1.43%885,468
Institutions80.89%50,089,989
Public float17.68%10,946,440

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 5

View all →
Insider% of sharesShares
Coulie BernardCEOPresident and CEO · Director
0.82%505,601
Cummings Keith LamontChief Financial Officer
0.48%297,214
Cheung LilyChief Human Resource Officer
0.07%44,847
Kuo MinnieChief Operating Officer
0.06%37,806
Crowell Gayle aDirector
——

Institutional holders 101

View all →
HolderValue% of shares
Tang Capital Management, LLC$7.74M9.92%
Blue Owl Capital Holdings LP$3.62M4.80%
Vanguard Group Inc$3.44M4.55%
Citadel Advisors LLC$3.15M4.17%
Two Sigma Investments, LP$2.84M3.64%
Woodline Partners LP$2.47M3.27%
Renaissance Technologies LLC$2.33M2.99%
Monaco Asset Management SAM$2.21M3.13%
Redmile Group, LLC$1.97M2.61%
Prosight Management, LP$1.90M2.51%

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q4 2024
as of
Barclays PLC
13F manager
TrimCommon Stock$-4.21M-320K
-75.84%
101,823
0.16% of shares
low
Q3 2023
as of
Barclays PLC
13F manager
AddCommon Stock$2.64M+152K
+165.29%
244,266
0.39% of shares
low
Q4 2023
as of
Barclays PLC
13F manager
AddCommon Stock$1.97M+109K
+44.47%
352,897
0.57% of shares
low
Q1 2026
as of
Two Sigma Investments, LP
13F manager
AddCommon Stock$1.64M+1.3M
+136.35%
2,253,138
3.64% of shares
low
Q2 2023
as of
Barclays PLC
13F manager
AddCommon Stock$1.45M+80K
+681.56%
92,076
0.15% of shares
low
Q1 2026
as of
Renaissance Technologies LLC
13F manager
AddCommon Stock$1.02M+807K
+77.17%
1,852,842
2.99% of shares
low
Q1 2026
as of
Millennium Management LLC
13F manager
AddCommon Stock$972.3K+772K
+188.75%
1,180,518
1.91% of shares
low
Q3 2024
as of
Barclays PLC
13F manager
AddCommon Stock$880.8K+79K
+22.91%
421,499
0.68% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Citadel Advisors LLCPassive13G———
Citadel Advisors LLCPassive13G———
Citadel Advisors LLCPassive13G———
Point72 Asset Management, L.P.Passive13G/A———
Morgan StanleyPassive13G/A———
Woodline Partners LPPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
PLRXCommon StockEquity729139105BBG00C8083N4